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 ANGPTL8 is a promising biomarker for early 
detection of T2D as well as for GDM in pregnant 
women.
 Most studies have shown that ANGPTL8 is increased 
in people with T2D, T1D, and GDM
 It is also increased in obese people and those with MetS.
 role of ANGPTL8 in the beta‐cell 
proliferation and insulin resistance is far 
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